In vitro proliferation and osteoblastic phenotype expression of cells derived from human vertebral lamina and iliac crest

Spine

Volumn 34, Issue 15, 2009, Pages 1549-1553

  Defino, Helton L A ^a   Da Silva Herrero, Carlos F P ^a   Crippa, Grasiele E ^a   Bellesini, Larissa Sverzut ^a   Beloti, Marcio M ^a   Rosa, Adalberto L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bone graft; Cell culture; Iliac crest; Osteoblastic cells; Vertebral lamina

Indexed keywords

ALIZARIN RED S; ALKALINE PHOSPHATASE; CARBON DIOXIDE; INTERCELLULAR ADHESION MOLECULE 1; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOGENIC PROTEIN 1; OSTEOPROTEGERIN; THYMOLPHTHALEIN; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR RUNX2; TRYPAN BLUE;

ARTICLE; BONE TRANSPLANTATION; CANCELLOUS BONE; CELL COUNT; CELL CULTURE; CELL ISOLATION; CELL PROLIFERATION; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; DONOR; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; ILIAC CREST; IN VITRO STUDY; MINERALIZATION; OSTEOBLAST; PH; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STAINING; TEMPERATURE; VERTEBRA;

BIOLOGICAL MARKERS; BONE MATRIX; BONE REGENERATION; BONE TRANSPLANTATION; CALCIFICATION, PHYSIOLOGIC; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; ILIUM; OSTEOBLASTS; OSTEOGENESIS; PHENOTYPE; SPINAL FUSION; SPINE;

EID: 67651156028     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e3181a9c087     Document Type: Article

References (28)

1. Albee FH. Transplantation of a portion of the tibia into the spine for Pott's disease: a preliminary report 1911. Clin Orthop Relat Res 2007;460:14-16
2. Hibbs RA. A report of fifty-nine cases of scoliosis treated by the fusion operation. Clin Orthop 1988;229:4-19.
3. May VR Jr, Mauck WR. Exploration of the spine for pseudarthrosis following spinal fusion in the treatment of scoliosis. Clin Orthop Relat Res 1967; 53:115-122
4. Steinmann JC, Herkowitz HN. Pseudarthrosis of the spine. Clin Orthop Relat Res 1992;284:80-90.
5. Vaccaro AR, Chiba K, Heller JG, et al. Bone grafting alternatives in spinal surgery. Spine J 2002;2:206-215
6. Sandhu HS, Grewal HS, Parvataneni H. Bone grafting for spinal fusion. Orthop Clin North Am 1999;30:685-698
7. Ahlmann E, Patzakis M, Roidis N, et al. Comparison of anterior and posterior iliac crest bone grafts in terms of harvest-site morbidity and functional outcomes. J Bone Joint Surg Am 2002;84A:716-720 (Pubitemid 34925028)
8. Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma 1989;3:192-219.
9. Steffen T, Downer P, Steiner B, et al. Minimally invasive bone harvesting tools. Eur Spine J 2000;9:S114-8.
10. Hirunyachote P, Adulkasem W. Posterolateral fusion with autogenous laminospinous process bone graft. J Med Assoc Thai 2002;85:1105-1112 (Pubitemid 36134969)
11. Beloti MM, Martins W Jr, Xavier SP, et al. In vitro osteogenesis induced by cells derived from sites submitted to sinus grafting with anorganic bovine bone. Clin Oral Implants Res 2008;19:48-54.
12. Beloti MM, de Oliveira PT, Gimenes R, et al. In vitro biocompatibility of a novel membrane of the composite poly(vinylidene-trifluoroethylene)/barium titanate. J Biomed Mater Res A 2006;79:282-288 (Pubitemid 44652027)
13. Rosa AL, Beloti MM. TAK-778 enhances osteoblast differentiation of human bone marrow cells. J Cell Biochem 2003;89:1148-1153 (Pubitemid 36959382)
14. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275
15. Gregory CA, Gunn WG, Peister A, et al. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem 2004;329:77-84. (Pubitemid 38596903)
16. Livak KL, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT Method. Methods 2001;25: 402-408 (Pubitemid 34164012)
17. Prolo DJ, Rodrigo JJ. Contemporary bone graft physiology and surgery. Clin Orthop Relat Res 1985;200:322-342
18. Martinez ME, Medina S, Sanchez M, et al. Influence of skeletal site of origin and donor age on 1,25(OH)2D3-induced response of various osteoblastic markers in human osteoblastic cells. Bone 1999;24:203-209 (Pubitemid 29094562)
19. Kasperk C, Wergedal J, Strong D, et al. Human bone cell phenotypes differ depending on their skeletal site of origin. J Clin Endocrinol Metab 1995;80: 2511-2517
20. Helms JA, Amasha RR, Leucht P. Bone voyage: an expedition into the molecular and cellular parameters affecting bone graft fate. Bone 2007; 41:479-485 (Pubitemid 47385441)
21. McLain RF, Fleming JE, Boehm CA, et al. Aspiration of osteoprogenitor cells for augmenting spinal fusion: comparison of progenitor cell concentrations from the vertebral body and iliac crest. J Bone Joint Surg 2005;87:2655-2661
22. Malaval L, Modrowski D, Gupta AK, et al. Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures. J Cell Physiol 1994;158:555-572 (Pubitemid 24094439)
23. Rosa AL, Beloti MM. Development of the osteoblast phenotype of serial cell subcultures from human bone marrow. Braz Dent J 2005;16:225-230
24. Beloti MM, Bellesini LS, Rosa AL. Purmorphamine enhances osteogenic activity of human osteoblasts derived from bone marrow mesenchymal cells. Cell Biol Int 2005;29:537-541 (Pubitemid 41138216)
25. Paredes R, Arriagada G, Cruzat F, et al. The Runx2 transcription factor plays a role in the 1alpha,25-dihydroxy Vitamin D3-dependent upregulation of the rat osteocalcin (OC) gene expression in osteoblastic cells. J Steroid Biochem Mol Biol 2004;89-90:269-271 (Pubitemid 38844293)
26. Camozzi V, Tossi A, Simoni E, et al. Role of biochemical markers of bone remodeling in clinical practice. J Endocrinol Invest 2007;30(suppl 6):13-7. 27.
27. Martin TJ, Sims NA. Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med 2005;11:76-81.
28. Laird AD, Li G, Moss KG, et al. Src family kinase activity is required for signal tranducer and activator of transcription 3 and focal adhesion kinase phosphorylation and vascular endothelial growth factor signaling in vivo and for anchorage-dependent and independent growth of human tumor cells. Mol Cancer Ther 2003;2:461-469